Article: Immusol Announces Appointment of Chief Financial Officer.

SAN DIEGO, Aug. 17 /PRNewswire/ -- Immusol announced today that Gerard A. Wills has joined the Company as its Chief Financial Officer.

Mr. Wills recently served as the Vice President, Chief Financial Officer and Treasurer of Nanogen, Inc., a developer of molecular and point-of-care diagnostic products. Prior to that Mr. Wills was the Chief Financial Officer, Vice President, Finance with Trega Biosciences, Inc. from 1999 until its acquisition by Lion Bioscience of Heidelberg, Germany in March 2001. From 1993 to 1999, Mr. Wills was the Chief Financial Officer, Vice President, Finance with Molecular Biosystems, Inc. and from 1990 to 1993 he was Corporate Manager ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!